Trust Point’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Trust Point's ABBV Position: Q3 2026 in Review
Trust Point increased its AbbVie (ABBV) stake by 1.5% in Q3 2026, buying an estimated $39.7K and bringing the position to 10,288 shares worth $2.69M. The position accounts for 0.2% of the portfolio, ranked #59.
Trust Point first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Trust Point held 10,288 shares of AbbVie worth $2.69M as of Q3 2026.
- Trust Point bought 155 AbbVie shares in Q3 2026, an estimated $39.7K.
- AbbVie made up 0.2% of Trust Point's portfolio in Q3 2026, its #59 holding.
- Trust Point first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
- 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.